Myeloperoxidase: Friend and foe

Journal of Leukocyte Biology

Volumn 77, Issue 5, 2005, Pages 598-625

  Klebanoff, Seymour J ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Hydrogen peroxide; Hypochlorous acid; MPO deficiency; MPO independent antimicrobial systems; Myeloperoxidase mediated antimicrobial system; Neutrophil microbicidal activity

Indexed keywords

ANTIBODY; CHLORAMINE DERIVATIVE; CHLORIDE; CHLORINE; COMPLEMENT; HALIDE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPOCHLOROUS ACID; MYELOPEROXIDASE; OPSONIN; OZONE; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN;

ANTIMICROBIAL ACTIVITY; CELL GRANULE; DEGRANULATION; HUMAN; MICROORGANISM; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOGENESIS; PHAGOCYTE; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; REVIEW; TISSUE INJURY;

ANIMALS; ARTERIOSCLEROSIS; HUMANS; HYDROGEN PEROXIDE; LUNG DISEASES; NEOPLASMS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEROXIDASE; PHAGOCYTOSIS; RESPIRATORY BURST;

EID: 18244390487     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1204697     Document Type: Review

References (497)

1. Klebanoff, S. J. (1959) An effect of thyroxine and related compounds on the oxidation of certain hydrogen donors by the peroxidase system. J. Biol. Chem. 234, 2437-2442.
2. Klebanoff, S. J. (1959) An effect of thyroxine on the oxidation of reduced pyridine nucleotides by the peroxidase system. J. Biol. Chem. 234, 2480-2485.
3. Morrison, M., Hultquist, D. E. (1963) Lactoperoxidase. II. Isolation. J. Biol. Chem. 238, 2843-2849.
4. Agner, K. (1958) Crystalline myeloperoxidase. Acta Chem. Scand. A 12, 89-94.
5. Klebanoff, S. J., Yip, C., Kessler, O. (1962) The iodination of tyrosine by beef thyroid preparations. Biochim. Biophys. Acta 58, 563-574.
6. Agner, K. (1941) Verdoperoxidase. A ferment isolated from leucocytes. Acta Chem. Scand. A 2 (Suppl. 8). 1-62.
7. Schultz, J., Kaminker, K. (1962) Myeloperoxidase of the leucocyte of normal human blood. 1. Content and localization. Arch. Biochem. Biophys. 96, 465-467.
8. Kinkade Jr., J. M., Pember, S. O., Barnes, K. C., Shapira, R., Spitznagel, J. K., Martin, L. E. (1983) Differential distribution of distinct forms of myeloperoxidase in different azurophilic granule subpopulations from human neutrophils. Biochem. Biophys. Res. Commun. 114, 296-303.
9. Bainton, D. F., Ullyot, J. L., Farquhar, M. G. (1971) The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. Origin and content of azurophil and specific granules. J. Exp. Med. 134, 907-934.
10. Nichols, B. A., Bainton, D. F. (1973) Differentiation of human monocytes in bone marrow and blood. Sequential formation of two granule populations. Lab. Invest. 29, 27-40.
11. Bainton, D. F., Farquhar, M. G. (1970) Segregation and packaging of granule enzymes in eosinophilie leukocytes. J. Cell Biol. 45, 54-73.
12. Klebanoff, S. J. (1999) Oxygen metabolites from phagocytes. In Inflammation: Basic Principles and Clinical Correlates (J. I. Gallin and R. Snyderman, eds.), Philadel|ihia, PA, Lippincolt Williams & Wilkins, 721-768.
13. Chang, K. S., Trujillo, J. M., Cook, R. G., Stass, S. A. (1986) Human myeloperoxidase gene: molecular cloning and expression in leukemic cells. Blood 68, 1411-1414.
14. Yamada, M., Hur, S-J., Hashinaka, K., Tsuneoka, K., Saeki, T., Nishio, C., Sakiyama, F., Tsunasawa, S. (1987) Isolation and characterization of a cDNA coding for human myeloperoxidase. Arch. Biochem. Biophys. 255, 147-155.
15. Morishita, K., Kubota, N., Asano, S., Kaziro, Y., Nagata, S. (1987) Molecular cloning and characterization of cDNA for human myeloperoxidase. J. Biol. Chem. 262, 3844-3851.
16. Johnson, K. R., Nauseef, W. M., Care, A., Wheelock, M. J., Shane, S., Hudson, S., Koeffler, H. P., Selsted, M., Miller, C., Rovera, G. (1987) Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species. Nucleic Acids Res. 15, 2013-2028.
17. Weil, S. C., Rosner, G. L., Reid, M. S., Chisholm, R. L., Farber, N. M., Spitznagel, J. K., Swanson, M. S. (1987) cDNA cloning of human myeloperoxidase: decrease in myeloperoxidase mRNA upon induction of HL-60 cells. Proc. Natl. Acad. Sci. USA 84, 2057-2061.
18. Venturelli, D., Bittenbender, S., Rovera, G. (1989) Sequence of the murine myeloperoxidase (MPO) gene. Nucleic Acids Res. 17, 7987-7988.
19. Hosokawa, Y., Kawaguchi, R., Hikiji, K., Yamada, M., Suzuki, K., Nakagawa, T., Yoshihara, T., Yamaguchi, K. (1993) Cloning and characterization of four types of cDNA encoding myeloperoxidase from human monocytic leukemia cell line, SKM-1. Leukemia 7, 441-445.
20. Johnson, K. R., Nauseef, W. M. (1991) Molecular biology of MPO. In Peroxidases in Chemistry and Biology, vol. I (J. Everse, K. E. Everse, and M. B. Grisham, eds.), Boca Raton, FL, CRC, 63-81.
21. Chang, K. S., Schroeder, W., Siciliano, M. J., Thompson, L. H., McCredie, K., Beran, M., Freireich, E. J., Liang, J. C., Trujillo, J. M., Stass, S. A. (1987) The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemia. Leukemia 1, 458-462.
22. Inazawa, J., Inoue, K., Nishigaki, H., Tsuda, S., Taniwaki, M., Misawa, S., Abe, T. (1989) Assignment of the human myeloperoxidase gene (MPO) to bands q21.3 → q23 of chromosome 17. Cytogenet. Cell Genet. 50, 135-136.
23. Zaki, S. R., Austin, G. E., Chan, W. C., Conaty, A. L., Trusler, S., Trappier, S., Lindsey, R. B., Swan, D. C. (1990) Chromosomal localization of the human myeloperoxidase gene by in situ hybridization using oligonucleotide probes. Genes Chromosomes Cancer 2, 266-270.
24. Nauseef, W. M., Olsson, I., Arnljots, K. (1988) Biosynthesis and processing of myeloperoxidase-a marker for myeloid cell differentiation. Eur. J. Haematol. 40, 97-110.
25. Stromberg, J., Persson, A-M., Olsson, I. (1986) The processing and intracellular transport of myeloperoxidase. Modulation by lysosomotropic agents and monensin. Eur. J. Cell Biol. 39, 424-431.
26. Nauseef, W. M. (1986) Myeloperoxidase biosynthesis by a human promyelocytic leukemia cell line: insight into myeloperoxidase deficiency. Blood 67, 865-872.
27. Nauseef, W. M., McCormick, S. J., Clark, R. A. (1995) Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J. Biol. Chem. 270, 4741-4747.
28. Nauseef, W. M., McCormick, S. J., Goedken, M. (1998) Coordinated participation of calreticulin and calnexin in the biosynthesis of myeloperoxidase. J. Biol. Chem. 273, 7107-7111.
29. Nauseef, W. M., McCormick, S., Yi, H. (1992) Roles of heme insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysosomal enzyme, myeloperoxidase. Blood 80, 2622-2633.
30. Pinnix, I. B., Guzman, G. S., Bonkovsky, H. L., Zaki, S. R., Kinkade Jr., J. M. (1994) The post-translational processing of myeloperoxidase is regulated by the availability of heme. Arch. Biochem. Biophys. 312, 447-458.
31. Nauseef, W. M., Cogley, M., McCormick, S. (1996) Effect of the R569W missense mutation on the biosynthesis of myeloperoxidase. J. Biol. Chem. 271, 9546-9549.
32. Andrews, P. C., Krinsky, N. I. (1981) The reductive cleavage of myeloperoxidase in half, producing enzymatically active hemi-myeloperoxidase. J. Biol. Chem. 256, 4211-4218.
33. Harrison, J. E., Pabalan, S., Schultz, J. (1977) The subunit structure of crystalline canine myeloperoxidase. Biochim. Biophys. Acta 493, 247-259.
34. Olsen, R. L., Little, C. (1984) Studies on the subunits of human myeloperoxidase. Biochem. J. 222, 701-709.
35. Atkin, C. L., Andersen, M. R., Eyre, H. J. (1982) Abnormal neutrophil myeloperoxidase from a patient with chronic myelocytic leukemia. Arch. Biochem. Biophys. 214, 284-292.
36. Andrews, P. C., Parnes, C., Krinsky, N. I. (1984) Comparison of myeloperoxidase and hemi-myeloperoxidase with respect to catalysis, regulation, and bactericidal activity. Arch. Biochem. Biophys. 228, 439-442.
37. Nauseef, W. M., Malech, H. L. (1986) Analysis of the peptide subunits of human neutrophil myeloperoxidase. Blood 67, 1504-1507.
38. Taylor, K. L., Guzman, G. S., Pohl, J., Kinkade Jr., J. M. (1990) Distinct chromatographic forms of human hemi-myeloperoxidase obtained by reductive cleavage of the dimeric enzyme. J. Biol. Chem. 265, 15938-15946.
39. Fenna, R. E. (1987) Crystallization and subunit structure of canine myeloperoxidase. J. Mol. Biol. 196, 919-925.
40. Zeng, J., Fenna, R. E. (1989) Tetragonal crystals of canine myeloperoxidase suitable for X-ray structural analysis. J. Mol. Biol. 210, 681-683.
41. Zeng, J., Fenna, R. E. (1992) X-ray crystal structure of canine myeloperoxidase at 3 Å resolution. J. Mol. Biol. 226, 185-207.
42. Fenna, R., Zeng, J., Davey, C. (1995) Structure of the green heme in myeloperoxidase. Arch. Biochem. Biophys. 316, 653-656.
43. Sutton, B. J., Little, C., Olsen, R. L., Willassen, N. P. (1988) Preliminary crystallographic analysis of human myeloperoxidase. J. Mol. Biol. 199, 395-396.
44. Graham, G. S. (1920) The neutrophilic granules of the circulating blood in health and in disease. A preliminary report. N. Y. State J. Med. 20, 46-55.
45. Hirsch, J. G., Cohn, Z. A. (1960) Degranulation of polymorphonuclear leucocytes following phagocytosis of microorganisms. J. Exp. Med. 112, 1005-1014.
46. Cohn, Z. A., Hirsch, J. G. (1960) The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leukocytes. J. Exp. Med. 112, 1015-1022.
47. Skarnes, R. C., Watson, D. W. (1956) Characterization of leukin: an antibacterial factor from leucocytes active against gram-positive pathogens. J. Exp. Med. 104, 829-845.
48. Hirsch, J. G. (1956) Phagocytin: a bactericidal substance from polymorphonuclear leucocytes. J. Exp. Med. 103, 589-611.
49. Klebanoff, S. J. (1970) Myeloperoxidase-mediated antimicrobial systems and their role in leukocyte function. In Biochemistry of the Phagocytic Process (J. Schultz, ed.), Amsterdam, North Holland, 89-110.
50. Edwards, S. W., Nurcombe, H. L., Hart, C. A. (1987) Oxidative inactivation of myeloperoxidase released from human neutrophils. Biochem. J. 245, 925-928.
51. King, C. C., Jefferson, M. M., Thomas, E. L. (1997) Secretion and inactivation of myeloperoxidase by isolated neutrophils. J. Leukoc. Biol. 61, 293-302.
52. Schmekel, B., Hornblad, Y., Linden, M., Sundstrom, C., Venge, P. (1990) Myeloperoxidase in human lung lavage. II. Internalization of myeloperoxidase by alveolar macrophages. Inflammation 14, 455-461.
53. Shepherd, V. L., Hoidal, J. R. (1990) Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am. J. Respir. Cell Mol. Biol. 2, 335-340.
54. - system. J. Infect. Dis. 137, 481-485.
55. Ramsey, P. G., Martin, T., Chi, E., Klebanoff, S. J. (1982) Arming of mononuclear phagocytes by eosinophil peroxidase bound to Staphylococcus aureus. J. Immunol. 128, 415-420.
56. Noqueira, N. M., Klebanoff, S. J., Cohn, Z. A. (1982) T. cruzi: sensitization to macrophage killing by eosinophil peroxidase. J. Immunol. 128, 1705-1708.
57. Locksley, R. M., Wilson, C. B., Klebanoff, S. J. (1982) Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes. J. Clin. Invest. 69, 1099-1111.
58. Sbarra, A. J., Karnovsky, M. L. (1959) The biochemical basis of phagocytosis. 1. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J. Biol. Chem. 234, 1355-1362.
59. Sbarra, A. J., Karnovsky, M. L. (1960) The biochemical basis of phagocytosis. 2. Incorporation of C14-labeled building blocks into lipid, protein, and glycogen of leukocytes during phagocytosis. J. Biol. Chem. 235, 2224-2229.
60. Baldridge, C. W., Gerard, R. W. (1933) The extra respiration of phagocytosis. Am. J. Physiol. 103, 235-236.
61. Iyer, G. Y. N., Islam, D. M. F., Quastel, J. H. (1961) Biochemical aspects of phagocytosis. Nature 192, 535-541.
62. Kojima, S. (1931) Studies on peroxidase. II. The effect of peroxidase on the bactericidal action of phenols. J. Biochem. 14, 95-109.
63. Zeldow, B. J. (1959) Studies on the antibacterial activity of human saliva. I. A bactericidin for lactobacilli. J. Dent. Res. 38, 798-804.
64. Dogon, I. L., Kerr, A. C., Amdur, B. H. (1962) Characterization of an antibacterial factor in human parotid secretions, active against Lactobacillus casei. Arch. Oral Biol. 7, 81-90.
65. Klebanoff, S. J., Luebke, R. G. (1965) The antilactobacillus system of saliva. Role of salivary peroxidase. Proc. Soc. Exp. Biol. Med. 118, 483-486.
66. Klebanoff, S. J., Clem, W. H., Luebke, R. G. (1966) The peroxidase-thiocyanate-hydrogen peroxide antimicrobial system. Biochim. Biophys. Acta 117, 63-72.
67. Reiter, B., Pickering, A., Oram, J. D. (1964) An inhibitory system-lactoperoxidase/thiocyanate/peroxide-in raw milk. 4th Inernationaional Symposium on Food Microbiology SIK, Goteborg, Sweden, 297-305.
68. Klebanoff, S. J. (1967) A peroxidase-mediated antimicrobial system in leukocytes. J. Clin. Invest. 46, 1078A.
69. Klebanoff, S. J. (1967) Iodination of bacteria: a bactericidal mechanism. J. Exp. Med. 126, 1063-1078.
70. Klebanoff, S. J. (1968) Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J. Bacteriol. 95, 2131-2138.
71. Klebanoff, S. J. (1999) Myeloperoxidase. Proc. Assoc. Am. Physicians 111, 383-389.
72. McRipley, R. J., Sbarra, A. J. (1967) Role of the phagocyte in host-parasite interactions. XII. Hydrogen peroxide-myeloperoxidase bactericidal system in the phagocyte. J. Bacteriol. 94, 1425-1430.
73. 2-chloride anti-microbial system: A possible in vivo mechanism of action. Infect. Immun. 2, 414-418.
74. Rossi, F., Zatti, M. (1964) Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia 20, 21-23.
75. Babior, B. M., Kipnes, R. S., Curnutte, J. T. (1973) Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 52, 741-744.
76. Babior, B. M., Lambeth, J. D., Nauseef, W. (2002) The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397, 342-344.
77. Babior, B. M. (2004) NADPH oxidase. Curr. Opin. Immunol. 16, 42-47.
78. Roos, D., van Bruggen, R., Meischl, C. (2003) Oxidative killing of microbes by neutrophils. Microbes Infect. 5, 1307-1315.
79. Quinn, M. T., Gauss, K. A. (2004) Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J. Leukoc. Biol. 76, 760-781.
80. Bromberg, Y., Pick, E. (1984) Unsaturated fatty acids stimulate NADPH-dependent superoxide production by cell-free system derived from macrophages. Cell. Immunol. 88, 213-221.
81. Heyneman, R. A., Vercauteren, R. E. (1984) Activation of a NADPH oxidase from horse polymorphonuclear leukocytes in a cell-free system. J. Leukoc. Biol. 36, 751-759.
82. Bromberg, Y., Pick, E. (1985) Activation of NADPH-dependent superoxide production in a cell-free system by sodium dodecyl sulfate. J. Biol. Chem. 260, 13539-13545.
83. Segal, A. W., Jones, O. T. (1978) Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature 276, 515-517.
84. -245 of neutrophils is also present in human monocytes, macrophages and eosinophils. Biochem. J. 196, 363-367.
85. Royer-Pokora, B., Kunkel, L. M., Monaco, A. P., Goff, S. C., Newburger, P. E., Baelmer, R. L., Cole, F. S., Curnutte, J. T., Orkin, S. H. (1986) Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature 322, 32-38.
86. Orkin, S. H. (1986) Reverse genetics and human disease. Cell 47, 845-850.
87. Abo, A., Pick, E., Hall, A., Totty, N., Teahan, C. G., Segal, A. W. (1991) Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353, 668-670.
88. Knaus, U. G., Heyworth, P. G., Evans, T., Curnutte, J. T., Bokoch, G. M. (1991) Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science 254, 1512-1515.
89. Heyworth, P. G., Bohl, B. P., Bokoch, G. M., Curnutte, J. T. (1994) Rac translocates independently of the neutrophil NADPH oxidase components p47phox and p67phox. Evidence for its interaction with flavocytochrome b558. J. Biol. Chem. 269, 30749-30752.
90. Volpp, B. D., Nauseef, W. M., Clark, R. A. (1988) Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science 242, 1295-1297.
91. Volpp, B. D., Nauseef, W. M., Donelson, J. E., Moser, D. R., Clark, R. A. (1989) Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc. Natl. Acad. Sci. USA 86, 7195-7199.
92. Leto, T. L., Lomax, K. J., Volpp, B. D., Nunoi, H., Sechler, J. M., Nauseef, W. M., Clark, R. A., Gallin, J. I., Malech, H. L. (1990) Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science 248, 727-730.
93. Bokoch, G. M., Diebold, B. A. (2002) Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 100, 2692-2696.
94. Quie, P. G., White, J. G., Holmes, B., Good, R. A. (1967) In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J. Clin. Invest. 46, 668-679.
95. Berendes, H., Bridges, R. A., Good, R. A. (1957) A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn. Med. 40, 309-312.
96. Holmes, B., Page, A. R., Good, R. A. (1967) Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J. Clin. Invest. 46, 1422-1432.
97. Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L., Holland, S. M. (2000) Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79, 170-200.
98. Heyworth, P. G., Cross, A. R., Curnutte, J. T. (2003) Chronic granulomatous disease. Curr. Opin. Immunol. 15, 578-584.
99. Segal, A. W., Jones, O. T., Webster, D., Allison, A. C. (1978) Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease. Lancet 2, 446-449.
100. Dinauer, M. C., Curnutte, J. T., Rosen, H., Orkin, S. H. (1989) A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease. J. Clin. Invest. 84, 2012-2016.
101. Nunoi, H., Rotrosen, D., Gallin, J. I., Malech, H. L. (1988) Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science 242, 1298-1301.
102. Ambruso, D. R., Knall, C., Abell, A. N., Panepinto, J., Kurkchubasche, A., Thurman, G., Gonzalez-Aller, C., Hiester, A., deBoer, M., Harbeck, R. J., Oyer, R., Johnson, C. L., Roos, D. (2000) Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc. Natl. Acad. Sci. USA 97, 4654-4659.
103. Williams, D. A., Tao, W., Yang, F., Kim, C., Gu, Y., Mansfield, P., Levine, J. E., Petryniak, B., Derrow, C. W., Harris, C., Jia, B., Zheng, Y., Ambruso, D. R., Lowe, J. B., Atkinson, S. J., Dinauer, M. C., Boxer, L. (2000) Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 96, 1646-1654.
104. Kurkchubasche, A. G., Panepinto, J. A., Tracy Jr., T. F., Thurman, G. W., Ambruso, D. R. (2001) Clinical features of a human Rac2 mutation: a complex neutrophil dysfunction disease. J. Pediatr. 139, 141-147.
105. Warnholtz, A., Nickenig, G., Schulz, E., Macharzina, R., Brasen, J. H., Skatchkov, M., Heitzer, T., Stasch, J. P., Griendling, K. K., Harrison, D. G., Bohm, M., Meinertz, T., Munzel, T. (1999) Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99, 2027-2033.
106. Yokoyama, M., Inoue, N., Kawashima, S. (2000) Role of the vascular NADH/NADPH oxidase system in atherosclerosis. Ann. N. Y. Acad. Sci. 902, 241-247.
107. Griendling, K. K., Sorescu, D., Ushio-Fukai, M. (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501.
108. Sorescu, D., Szocs, K., Griendling, K. K. (2001) NAD(P)H oxidases and their relevance to atherosclerosis. Trends Cardiovasc. Med. 11, 124-131.
109. Souza, H. P., Laurindo, F. R., Ziegelstein, R. C., Berlowitz, C. O., Zweier, J. L. (2001) Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control. Am. J. Physiol. Heart Circ. Physiol. 280, H658-H667.
110. Zhang, C., Yang, J., Jacobs, J. D., Jennings, L. K. (2003) Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases. Am. J. Physiol. Heart Circ. Physiol. 285, H2563-H2572.
111. Eiserich, J. P., Baldus, S., Brennan, M. L., Ma, W., Zhang, C., Tousson, A., Castro, L., Lusis, A. J., Nauseef, W. M., White, C. R., Freeman, B. A. (2002) Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296, 2391-2394.
112. Bokoch, G. M., Knaus, U. G. (2003) NADPH oxidases: not just for leukocytes anymore! Trends Biochem. Sci. 28, 502-508.
113. Lambeth, J. D. (2004) NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181-189.
114. Suh, Y. A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., Lambeth, J. D. (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401, 79-82.
115. Shiose, A., Kuroda, J., Tsuruya, K., Hirai, M., Hirakata, H., Naito, S., Hattori, M., Sakaki, Y., Sumimoto, H. (2001) A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 276, 1417-1423.
116. Dupuy, C., Ohayon, R., Valent, A., Noel-Hudson, M. S., Deme, D., Virion, A. (1999) Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cdnas. J. Biol. Chem. 274, 37265-37269.
117. De Deken, X., Wang, D., Many, M. C., Costagliola, S., Libert, F., Vassart, G., Dumont, J. F., Miot, F. (2000) Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 275, 23227-23233.
118. Banfi, B., Molnar, G., Maturana, A., Steger, K., Hegedus, B., Demaurex, N., Krause, K. H. (2001) A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276, 37594-37601.
119. Geiszt, M., Kopp, J. B., Varnai, P., Leto, T. L. (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. USA 97, 8010-8014.
120. Banfi, B., Clark, R. A., Steger, K., Krause, K. H. (2003) Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278, 3510-3513.
121. Edens, W. A., Sharling, L., Cheng, G., Shapira, R., Kinkade, J. M., Lee, T., Edens, H. A., Tang, X., Sullards, C., Flaherty, D. B., Benian, G. M., Lambeth, J. D. (2001) Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J. Cell Biol. 154, 879-891.
122. Takeya, R., Ueno, N., Kami, K., Taura, M., Kohjima, M., Izaki, T., Nunoi, H., Sumimoto, H. (2003) Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J. Biol. Chem. 278, 25234-25246.
123. Cheng, G., Lambeth, J. D. (2004) NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J. Biol. Chem. 279, 4737-4742.
124. Banfi, B., Tirone, F., Durussel, I., Knisz, J., Moskwa, P., Molnar, G. Z., Krause, K. H., Cox, J. A. (2004) Mechanism of Ca2+ activation of the NADPH oxidase NOX5. J. Biol. Chem. 279, 18583-18591.
125. De Deken, X., Wang, D., Dumont, J. E., Miot, F. (2002) Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. Exp. Cell Res. 273, 187-196.
126. Moreno, J. C., Bikker, H., Kempers, M. J., van Trotsenburg, A. S., Baas, F., de Vijlder, J. J., Vulsma, T., Ris-Stalpers, C. (2002) Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N. Engl. J. Med. 347, 95-102.
127. Geiszt, M., Witta, J., Baffi, J., Lekstrom, K., Leto, T. L. (2003) Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 17, 1502-1504.
128. Granger, D. N., Rutili, G., McCord, J. M. (1981) Superoxide radicals in feline intestinal ischemia. Gastroenterology 81, 22-29.
129. Whittenbury, R. (1964) Hydrogen peroxide formation and catalase activity in the lactic acid bacteria. J. Gen. Microbiol. 35, 13-26.
130. Eschenbach, D. A., Davick, P. R., Williams, B. L., Klebanoff, S. J., Young-Smith, K., Critchlow, C. M., Holmes, K. K. (1989) Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 27, 251-256.
131. 2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J. Infect. Dis. 178, 446-450.
132. 2-generating lactobacilli. J. Infect. Dis. 164, 94-100.
133. Klebanoff, S. J. (1992) Effects of the spermicidal agent nonoxynol-9 on vaginal microbial flora. J. Infect. Dis. 165, 19-25.
134. Klebanoff, S. J., Coombs, R. W. (1991) Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J. Exp. Med. 174, 289-292.
135. Herzberg, M., Joel, C. A., Katchalsky, A. (1964) The cyclic variation of sodium chloride content in the mucus of the cervix uteri. Fertil. Steril. 15, 684-694.
136. Hooton, T. M., Klebanoff, S. J. (1993) Association of urogenital infections with spermicides. Infect. Med. 10, 40-47.
137. Hooton, T. M., Hillier, S., Johnson, C., Roberts, P. L., Stamm, W. E. (1991) Escherichia coli bacteriuria and contraceptive method. JAMA 265, 64-69.
138. McGroarty, J. A., Chong, S., Reid, G., Bruce, A. W. (1990) Influence of the spermicidal compound nonoxynol-9 on the growth and adhesion of urogenital bacteria in vitro. Curr. Microbiol. 21, 219-223.
139. Agner, K. (1958) Peroxidative oxidation of chloride ions. In Proceedings of the 4th International Congress on Biochemistry, Vienna, 15, 64A.
140. Agner, K. (1972) Biological effects of hypochlorous acid formed by "MPO"-peroxidation in the presence of chloride ions. In Structure and Function of Oxidation Reduction Enzymes, vol. 18 (A. Akeson and A. Ehrenberg, eds.), New York, NY, Pergamon, 329-335.
141. Harrison, J. E., Schultz, J. (1976) Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251, 1371-1374.
142. Odajima, T., Yamazaki, I. (1970) Myeloperoxidase of the leukocyte of normal blood. I. Reaction of myeloperoxidase with hydrogen peroxide. Biochim. Biophys. Acta 206, 71-77.
143. Marquez, L. A., Huang, J. T., Dunford, H. B. (1994) Spectral and kinetic studies on the formation of myeloperoxidase compounds I and II: roles of hydrogen peroxide and superoxide. Biochemistry 33, 1447-1454.
144. Furtmuller, P. G., Burner, U., Jantschko, W., Regelsberger, G., Obinger, C. (2000) The reactivity of myeloperoxidase compound I formed with hypochlorous acid. Redox Rep. 5, 173-178.
145. Harrison, J. E. (1976) The functional mechanism of myeloperoxidase. In Cancer Enzymology (J. Schultz and F. Ahmad, eds.), New York, NY, Academic, 305-317.
146. Kettle, A. J., Winterbourn, C. C. (1988) Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid. Biochem. J. 252, 529-536.
147. Kettle, A. J., Winterbourn, C. C. (1989) Influence of superoxide on myeloperoxidase kinetics measured with a hydrogen peroxide electrode. Biochem. J. 263, 823-828.
148. Kettle, A. J., Winterbourn, C. C. (1990) Superoxide enhances hypochlorous acid production by stimulated human neutrophils. Biochim. Biophys. Acta 1052, 379-385.
149. Bolscher, B. G. J. M., Zoutberg, G. R., Cuperus, R. A., Wever, R. (1984) Vitamin C stimulates the chlorinating activity of human myeloperoxidase. Biochim. Biophys. Acta 784, 189-191.
150. Marquez, L. A., Dunford, H. B., Van Wart, H. (1990) Kinetic studies on the reaction of compound II of myeloperoxidase with ascorbic acid. Role of ascorbic acid in myeloperoxidase function. J. Biol. Chem. 265, 5666-5670.
151. Kettle, A. J., Winterbourn, C. C. (1991) The influence of superoxide on the production of hypochlorous acid by human neutrophils. Free Radic. Res. Commun. 12-13, 47-52.
152. Marquez, L. A., Dunford, H. B. (1990) Reaction of compound III of myeloperoxidase with ascorbic acid. J. Biol. Chem. 265, 6074-6078.
153. Odajima, T., Yamazaki, I. (1972) Myeloperoxidase of the leukocyte of normal blood. III. The reaction of ferric myeloperoxidase with superoxide anion. Biochim. Biophys. Acta 284, 355-359.
154. Winterbourn, C. C., Garcia, R. C., Segal, A. W. (1985) Production of the superoxide adduct of myeloperoxidase (compound III) by stimulated human neutrophils and its reactivity with hydrogen peroxide and chloride. Biochem. J. 228, 583-592.
155. Metodiewa, D., Dunford, H. B. (1989) The reactions of horseradish peroxidase, lactoperoxidase, and myeloperoxidase with enzymatically generated superoxide. Arch. Biochem. Biophys. 272, 245-253.
156. Kettle, A. J., Sangster, D. F., Gebicki, J. M., Winterbourn, C. C. (1988) A pulse radiolysis investigation of the reactions of myeloperoxidase with superoxide and hydrogen peroxide. Biochim. Biophys. Acta 956, 58-62.
157. Wittenberg, J. B., Noble, R. W., Wittenberg, B. A., Antonini, E., Brunori, M., Wyman, J. (1967) Studies on the equilibria and kinetics of the reactions of peroxidase with ligands. II. The reaction of ferroperoxidase with oxygen. J. Biol. Chem. 242, 626-634.
158. Yamazaki, I., Yokota, K. N. (1973) Oxidation states of peroxidase. Mol. Cell. Biochem. 2, 39-52.
159. Phelps, C. F., Antonini, E., Giacometti, G., Brunori, M. (1974) The kinetics of oxidation of ferroperoxidase by molecular oxygen. Biochem. J. 141, 265-272.
160. Tamura, M., Yamazaki, I. (1972) Reactions of the oxyform of horseradish peroxidase. J. Biochem. (Tokyo) 71, 311-319.
161. Yokota, K., Yamazaki, I. (1965) Reaction of peroxidase with reduced nicotinamide-adenine dinucleotide and reduced nicotinamide-adenine dinucleotide phosphate. Biochim. Biophys. Acta 105, 301-312.
162. Yokota, K., Yamazaki, I. (1965) The activity of the horseradish peroxidase compound III. Biochem. Biophys. Res. Commun. 18, 48-53.
163. Hazen, S. L., Hsu, F. F., Mueller, D. M., Crowley, J. R., Heinecke, J. W. (1996) Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 98, 1283-1289.
164. Hazen, S. L., Hsu, F. F., Duffin, K., Heinecke, J. W. (1996) Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J. Biol. Chem. 271, 23080-23088.
165. Henderson, J. P., Byun, J., Heinecke, J. W. (1999) Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA. J. Biol. Chem. 274, 33440-33448.
166. Winterbourn, C. C. (2002) Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 181-182, 223-227.
167. Albrich, J. M., Gilbaugh, J. H. I., Callahan, K. B., Hurst, J. K. (1986) Effects of the putative neutrophil-generating toxin, hypochlorous acid, on membrane permeability and transport systems of Escherichia coli. J. Clin. Invest. 78, 177-184.
168. Rakita, R. M., Michel, B. R., Rosen, H. (1990) Differential inactivation of Escherichia coli membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system. Biochemistry 29, 1075-1080.
169. Barrette Jr., W. C., Albrich, J. M., Hurst, J. K. (1987) Hypochlorous acid-promoted loss of metabolic energy in Escherichia coli. Infect. Immun. 55, 2518-2525.
170. Rosen, H., Orman, J., Rakita, R. M., Michel, B. R., VanDevanter, D. R. (1990) Loss of DNA-membrane interactions and cessation of DNA synthesis in myeloperoxidase-treated Escherichia coli. Proc. Natl. Acad. Sci. USA 87, 10048-10052.
171. Hazen, S. L., d'Avignon, A., Anderson, M. M., Hsu, F. F., Heinecke, J. W. (1998) Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize α-amino acids to a family of reactive aldehydes. Mechanistic studies identifying labile intermediates along the reaction pathway. J. Biol. Chem. 273, 4997-5005.
172. Hazen, S. L., Hsu, F. F., d'Avignon, A., Heinceke, J. W. (1998) Human neutrophils employ myeloperoxidase to convert α-amino acids to a battery of reactive aldehydes: a pathway for aldehyde generation at sites of inflammation. Biochemistry 37, 6864-6873.
173. Soupart, P. (1962) Free amino acids in blood and urine in the human. In Amino Acid Pools (J. T. Holden, ed.), Amsterdam. Elsevier. 220-262.
174. Learn, D. B., Fried, V. A., Thomas, E. L. (1990) Taurine and hypotaurine content of human leukocytes. J. Leukoc. Biol. 48, 174-182.
175. Schuller-Levis, G. B., Park, E. (2003) Taurine: new implications for an old amino acid. FEMS Microbiol. Lett. 226, 195-202.
176. Peskin, A. V., Winterbourn, C. C. (2003) Histamine chloramine reactivity with thiol compounds, ascorbate, and methionine and with intracellular glutathione. Free Radic. Biol. Med. 35, 1252-1260.
177. Domigan, N. M., Charlton, T. S., Duncan, M. W., Winterbourn, C. C.,
178. Heinecke, J. W., Li, W., Daehnke III, H. L., Goldstein, J. A. (1993) Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 268, 4069-4077.
179. Savenkova, M. I., Mueller, D. M., Heinecke, J. W. (1994) Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269, 20394-20400.
180. Jacob, J. S., Cistola, D. P., Hsu, F. F., Muzaffar, S., Mueller, D. M., Hazen, S. L., Heinecke, J. W. (1996) Human phagocytes employ the myeloperoxidase-hydrogen peroxide system to synthesize dityrosine trityrosine, pulcherosine, and isodilyrosine by a tyrosyl radical-dependent pathway. J. Biol. Chem. 271, 19950-19956.
181. Heinecke, J. W., Li, W., Francis, G. A., Goldstein, J. A. (1993) Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J. Clin. Invest. 91, 2866-2872.
182. Winterbourn, C. C., Pichorner, H., Kettle, A. J. (1997) Myeloperoxidase-dependent generation of a tyrosine peroxide by neutrophils. Arch. Biochem. Biophys. 338, 15-21.
183. Fenton, H. J. H. (1894) Oxidation of tartaric acid in the presence of iron. J. Chem. Soc. 65, 899-910.
184. Haber, F., Weiss, J. (1934) The catalytic decomposition of hydrogen peroxide by iron salts. Proc. R. Soc. Lond. A 147, 332-351.
185. Ramos, C. L., Pou, S., Britigan, B. E., Cohen, M. S., Rosen, G. M. (1992) Spin trapping evidence for myeloperoxidase-dependent hydroxyl radical formation by human neutrophils and monocyles. J. Biol. Chem. 267, 8307-8312.
186. Lymar, S. V., Hurst, J. K. (1995) Role of compartmentation in promoting toxicity of leukocyte-generated strong oxidants. Chem. Res. Toxicol. 8, 833-840.
187. Foote, C. S., Abakerli, R. B., Clough, R. L., Lehrer, R. I. (1980) On the question of singlet oxygen production in polymorphonuclear leucocytes. In Bioluminescence and Chemiluminescence (M. A. DeLuca and W. D. McElroy, eds.), New York, NY, Academic, 81-88.
188. Foote, C. S., Abakerli, R. B., Clough, R. L., Shook, F. C. (1980) On the question of singlet oxygen production in leukocytes, macrophages and the dismutation of superoxide anion. Dev. Biochem. 11B, 222-230.
189. Kanofsky, J. R., Wright, J., Miles-Richardson, G. E., Tauber, A. I. (1984) Biochemical requirement for singlet oxygen production by purified human myeloperoxidase. J. Clin. Invest. 74, 1489-1495.
190. 2-halide system. Blood 62, 82a.
191. Steinbeck, M. J., Khan, A. U., Karnovsky, M. J. (1992) Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coaled with a chemical trap. J. Biol. Chem. 267, 13425-13433.
192. Arisawa, F., Tatsuzawa, H., Kambayashi, Y., Kuwano, H., Fujimori, K., Nakano, M. (2003) MCLA-dependent chemiluminescence suggests that singlet oxygen plays a pivotal role in myeloperoxidase-catalyzed bactericidal action in neutrophil phagosomes. Luminescence 18, 229-238.
193. 2-chloride system. FEBS Lett. 443, 154-158.
194. Wentworth, A. D., Jones, L. H., Wentworth Jr., P., Janda, K. D., Lerner, R. A. (2000) Antibodies have the intrinsic capacity to destroy antigens. Proc. Natl. Acad. Sci. USA 97, 10930-10935.
195. Wentworth Jr., P., Jones, L. H., Wentworth, A. D., Zhu, X., Larsen, N. A., Wilson, I. A., Xu, X., Goddard III, W. A., Janda, K. D., Eschenmoser, A., Lerner, R. A. (2001) Antibody catalysis of the oxidation of water. Science 293, 1806-1811.
196. Wentworth Jr., P., McDunn, J. E., Wentworth, A. D., Takenchi, C., Nieva, J., Jones, T., Bautista, C., Buedi, J. M., Gutierrez, A., Janda, K. D., Babior, B. M., Eschenmoser, A., Lerner, R. A. (2002) Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 298, 2195-2199.
197. Wentworth Jr., P., Wentworth, A. D., Zhu, X., Wilson, I. A., Janda, K. D., Eschenmoser, A., Lerner, R. A. (2003) Evidence for the production of trioxygen species during antibody-catalyzed chemical modification of antigens. Proc. Natl. Acad. Sci. USA 100, 1490-1493.
198. Babior, B. M., Takeuchi, C., Ruedi, J., Gutierrez, A., Wentworth Jr., P. (2003) Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. USA 100, 3031-3034.
199. Kettle, A. J., Clark, B. M., Winterbourn, C. C. (2004) Superoxide converts indigo carmine to isatin sulfonic acid: implications for the hypothesis that neutrophils produce ozone. J. Biol. Chem. 279, 18521-18525.
200. Hampton, M. B., Kettle, A. J., Winterbourn, C. C. (1998) Inside the nentrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92, 3007-3017.
201. Winterbourn, C. C., Vissers, M. C., Kettle, A. J. (2000) Myeloperoxidase. Curr. Opin. Hematol. 7, 53-58.
202. Klebanoff, S. J. (1993) Reactive nitrogen intermediates and antimicrobial activity: role of nitrite. Free Radic. Biol. Med. 14, 351-360.
203. Gaut, J. P., Byun, J., Tran, H. D., Lauber, W. M., Carroll, J. A., Hotchkiss, R. S., Belaaouaj, A., Heinecke, J. W. (2002) Myeloperoxidase produces nitrating oxidants in vivo. J. Clin. Invest. 109, 1311-1319.
204. Klebanoff, S. J., Green, W. L. (1973) Degradation of thyroid hormones by phagocytosing human leukocytes. J. Clin. Invest. 52, 60-72.
205. Woeber, K. A., Ingbar, S. H. (1973) Metabolism of L-thyroxine by phagocytosing human leukocytes. J. Clin. Invest. 52, 1796-1803.
206. Thomas, E. L., Fishman, M. (1986) Oxidation of chloride and thiocyanate by isolated leukocytes. J. Biol. Chem. 261, 9694-9702.
207. Gaut, J. P., Yell, G. C., Tran, H. D., Byun, J., Henderson, J. P., Richter, G. M., Brennan, M. L., Lusis, A. J., Belaaouaj, A., Hotchkiss, R. S., Heinecke, J. W. (2001) Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc. Natl. Acad. Sci. USA 98, 11961-11966.
208. van Dalen, C. J., Whitehouse, M. W., Winterbourn, C. C., Kettle, A. J. (1997) Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem. J. 327, 487-492.
209. Furtmuller, P. C., Burner, U., Obinger, C. (1998) Reaction of myeloperoxidase compound 1 with chloride, bromide, iodide, and thiocyanate. Biochemistry 37, 17923-17930.
210. Briggs, R. T., Karnovsky, M. L., Karnovsky, M. J. (1975) Cytochemical demonstration of hydrogen peroxide in the polymorphonuclear leukocyte phagosomes. J. Cell Biol. 64, 254-260.
211. Briggs, R. T., Drath, D. B., Karnovsky, M. L., Karnovsky, M. J. (1975) Localization of NADH oxidase on the surface of human polymorphonuclear leukocytes by a new cytochemical method. J. Cell Biol. 67, 566-586.
212. Briggs, R. T., Robinson, J. M., Karnovsky, M. L., Karnovsky, M. J. (1986) Superoxide production by polymorphonuclear leukocytes. A cytochemical approach. Histochemistry 84, 371-378.
213. Foote, C. S., Goyne, T. E., Lehrer, R. I. (1983) Assessment of chlorination by human neutrophils. Nature 301, 715-716.
214. Thomas, E. L., Grisham, M. B., Jefferson, M. M. (1983) Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J. Clin. Invest. 72, 441-454.
215. Weiss, S. J., Klein, R., Slivka, A., Wei, M. (1982) Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J. Clin. Invest. 70, 598-607.
216. Jiang, Q., Griffin, D. A., Barofsky, D. K., Hurst, J. K. (1997) Intraphagosomal chlorination dynamics and yields determined using unique fluorescent bacterial mimics. Chem. Res. Toxicol. 10, 1080-1089.
217. Griffin Jr., F. M., Griffin, J. A., Leider, J. E., Silverstein, S. C. (1975) Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane. J. Exp. Med. 142, 1263-1282.
218. Staudinger, B. J., Oberdoerster, M. A., Lewis, P. J., Rosen, H. (2002) mRNA expression profiles for Escherichia coli ingested by normal and phagocyte oxidase-deficient human neutrophils. J. Clin. Invest. 110, 1151-1163.
219. Root, R. K., Stossel, T. P. (1974) Myeloperoxidase-mediated iodination by granulocytes. Intracellular site of operation and some regulating factors. J. Clin. Invest. 53, 1207-1215.
220. Segal, A. W., Garcia, R. C., Harper, A. M. (1983) Iodination by stimulated human neutrophils. Studies on its stoichiometry, subcellular localization and relevance to microbial killing. Biochem. J. 210, 215-225.
221. Reeves, E. P., Nagl, M., Godovac-Zimmermann, J., Segal, A. W. (2003) Reassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyte. J. Med. Microbiol. 52, 643-651.
222. Klebanoff, S. J., Hamon, C. B. (1972) Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J. Reticuloendothel. Soc. 12, 170-196.
223. Odeberg, H., Olofsson, T., Olsson, I. (1974) Myeloperoxidase-mediated extracellular iodination during phagocytosis in granulocytes. Scand. J. Haematol. 12, 155-160.
224. Wu, W., Chen, Y., d'Avignon, A., Hazen, S. L. (1999) 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry 38, 3538-3548.
225. Buss, I. H., Senthilmohan, R., Darlow, B. A., Mogridge, N., Kettle, A. J., Winterbourn, C. C. (2003) 3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome. Pediatr. Res. 53, 455-462.
226. Hazen, S. L., Heinecke, J. W. (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99, 2075-2081.
227. van der Vliet, A., Nguyen, M. N., Shigenaga, M. K., Eiserich, J. P., Marelich, G. P., Cross, C. E. (2000) Myeloperoxidase and protein oxidation in cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L537-L546.
228. Lamb, N. J., Gutteridge, J. M., Baker, C., Evans, T. W., Quinlan, G. J. (1999) Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit. Care Med. 27, 1738-1744.
229. Chapman, A. L., Hampton, M. B., Senthilmohan, R., Winterbourn, C. C., Kettle, A. J. (2002) Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J. Biol. Chem. 277, 9757-9762.
230. Rosen, H., Crowley, J. R., Heinecke, J. W. (2002) Human neutrophils use the myeloperoxidase-hydrogen peroxide-chloride system to chlorinate but not nitrate bacterial proteins during phagocytosis. J. Biol. Chem. 277, 30463-30468.
231. Amin, V. M., Olson, N. F. (1968) Selective increase in hydrogen peroxide resistance of a coagulase-positive staphylococcus. J. Bacteriol. 95, 1604-1607.
232. Amin, V. M., Olson, N. F. (1968) Influence of catalase activity on resistance of coagulase-positive staphylococci to hydrogen peroxide. Appl. Microbiol. 16, 267-270.
233. Mandell, G. L. (1975) Catalase, superoxide dismutase, and virulence of Staphylococcus aureus. In vitro and in vivo studies with emphasis on staphylococcal-leukocyte interaction. J. Clin. Invest. 55, 561-566.
234. 2. Clin. Res. 22, 452A.
235. Johnston Jr., R. B., Baehner, R. L. (1970) Improvement of leukocyte bactericidal activity in chronic granulomatous disease. Blood 35, 350-355.
236. Ismail, G., Boxer, L. A., Baehner, R. L. (1979) Utilization of liposomes for correction of the metabolic and bactericidal deficiencies in chronic granulomatous disease. Pediatr. Res. 13, 769-773.
237. Gerber, C. E., Bruchelt, G., Falk, U. B., Kimpfler, A., Hauschild, O., Kuci, S., Bachi, T., Niethammer, D., Schubert, R. (2001) Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-oxidase-containing liposomes. Blood 98, 3097-3105.
238. Kaplan, E. L., Laxdal, T., Quie, P. G. (1968) Studies of polymorphonuclear leukocytes from patients with chronic granulomalous disease of childhood: bactericidal capacity for streptococci. Pediatrics 41, 591-599.
239. Klebanoff, S. J., White, L. R. (1969) Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood. N. Engl. J. Med. 280, 460-466.
240. Mandell, G. L., Hook, E. W. (1969) Leukocyte bactericidal activity in chronic granulomatous disease: correlation of bacterial hydrogen peroxide production and susceptibility to intracellular killing. J. Bacteriol. 100, 531-532.
241. Holmes, B., Good, R. A. (1972) Laboratory models of chronic granulomalous disease. J. Reticuloendothel. Soc. 12, 216-237.
242. Pitt, J., Bernheimer, H. P. (1974) Role of peroxide in phagocylic killing of pneumococci. Infect. Immun. 9, 48-52.
243. Shohet, S. B., Pitt, J., Baehner, R. L., Poplack, D. C. (1974) Lipid peroxidation in the killing of phagocytized pneumococci. Inject. Immun. 10, 1321-1328.
244. Klebanoff, S. J. (1970) Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 169, 1095-1097.
245. Koch, C. (1974) Effect of sodium azide upon normal and pathological granulocyte function. Acta Pathol. Microbiol. Scand. B 82, 136-142.
246. Lehrer, R. I. (1971) Inhibition by sulfonamides of the candidacidal activity of human neutrophils. J. Clin. Invest. 50, 2498-2505.
247. Korchak, H. M., Roos, D., Giedd, K. N., Wynkoop, E. M., Vienne, K., Rutherford, L. E., Buyon, J. P., Rich, A. M., Weissmann, G. (1983) Granulocytes without degranulation: neutrophil function in granule-depleted cytoplasts. Proc. Natl. Acad. Sci. USA 80, 4968-4972.
248. Roos, D., Voetman, A. A., Meerhof, L. J. (1983) Functional activity of enucleated human polymorphonuclear leukocytes. J. Cell Biol. 97, 368-377.
249. Odell, E. W., Segal, A. W. (1988) The bactericidal effects of the respiratory burst and the myeloperoxidase system isolated in neutrophil cytoplasts. Biochim. Biophys. Acta 971, 266-274.
250. Schock, L., Vercellotti, G., Stroncek, D., Jacob, H. S. (1984) Use of lysosome-free PMN cytoplasts ("neutroplasts") uncovers the critical role of myeloperoxidase for target cell lysis. Clin. Res. 32, 753A.
251. Stroncek, D. F., Vercellotti, G. M., Huh, P. W., Jacob, H. S. (1986) Neulrophil oxidants inactivate α-1-protease inhibitor and promote PMN-mediated detachment of cultured endothelium. Protection by free methionine. Arteriosclerosis 6, 332-340.
252. Lehrer, R. I., Cline, M. J. (1969) Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J. Clin. Invest. 48, 1478-1488.
253. Lehrer, R. I., Hanifin, J., Cline, M. J. (1969) Defective bactericidal activity in myeloperoxidase-deficient human neutrophils. Nature 223, 78-79.
254. Parry, M. F., Root, R. K., Metcalf, J. A., Delaney, K. K., Kaplow, L. S., Richar, W. J. (1981) Myeloperoxidase deficiency. Prevalence and clinical significance. Ann. Intern. Med. 95, 293-301.
255. Kutter, D. (1998) Prevalence of myeloperoxidase deficiency: population studies using Bayer-Technicon automated hematology, J. Mol. Med. 76, 669-675.
256. Suzuki, K., Nunoi, H., Miyazaki, M., Koi, F. (2000) Prevalence of inherited myeloperoxidase deficiency in Japan. In The Peroxidase Multigene Family of Enzymes. Biochemical Basis and Clinical Applications (P. E. Petrides and W. M. Nauseef, eds.), Berlin, Springer, 145-149.
257. Cramer, R., Soranzo, M. R., Dri, P., Rottini, G. D., Bramezza, M., Cirielli, S., Patriarca, P. (1982) Incidence of myeloperoxidase deficiency in an area of northern Italy: histochemical, biochemical and functional studies. Br. J. Haematol. 51, 81-87.
258. Hoy, A., Leininger-Muller, B., Kutter, D., Siest, G., Visvikis, S. (2002) Growing significance of myeloperoxidase in non-infectious diseases. Clin. Chem. Lab. Med. 40, 2-8.
259. Kutter, D., Devaquet, P., Vanderstocken, G., Paulus, J. M., Marchal, V., Gothot, A. (2000) Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol. 104, 10-15.
260. Aratani, Y., Koyama, H., Nyui, S., Suzuki, K., Kura, F., Maeda, N. (1999) Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect. Immun. 67, 1828-1836.
261. Aratani, Y., Kura, F., Watanabe, H., Akagawa, H., Takano, Y., Suzuki, K., Maeda, N., Koyama, H. (2000) Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. J. Infect. Dis. 182, 1276-1279.
262. Aratani, Y., Kura, F., Watanabe, H., Akagawa, H., Takano, Y., Suzuki, K., Dinauer, M. C., Maeda, N., Koyama, H. (2002) Critical role of myeloperoxidase and nicotinamide adenine dinucleolide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans. J. Infect. Dis. 185, 1833-1837.
263. Aratani, Y., Kura, F., Watanabe, H., Akagawa, H., Takano, Y., Suzuki, K., Dinauer, M. C., Maeda, N., Koyama, H. (2002) Relative contributions of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections with Candida albicans and Aspergillus fumigatus. Med. Mycol. 40, 557-563.
264. Rosen, H., Michel, B. R. (1997) Redundant contribution of myeloperoxidase-dependent systems to neutrophil-mediated killing of Escherichia coli. Infect. Immun. 65, 4173-4178.
265. Klebanoff, S. J., Clark, R. A. (1978) The Neutrophil: Function and Clinical Disorders, Amsterdam, North Holland.
266. Klebanoff, S. J., Pincus, S. H. (1971) Hydrogen peroxide utilization in myeloperoxidase-deficient leukocytes: a possible microbicidal control mechanism. J. Clin. Invest. 50, 2226-2229.
267. Cecil, P., Papathanassiou, A., Boreux, G., Roth, P., Miescher, P. A. (1979) Hereditary myeloperoxidase deficiency. Blood 53, 403-411.
268. Kitahara, M., Simonian, Y., Eyre, H. J. (1979) Neutrophil myeloperoxidase: a simple reproducible technique to determine activity. J. Lab. Clin. Med. 93, 232-237.
269. DeChatelet, L. R., Long, G. D., Shirley, P. S., Bass, D. A., Thomas, M. J., Henderson, F. W., Cohen, M. S. (1982) Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J. Immunol. 129, 1589-1593.
270. Nauseef, W. M., Root, R. K., Malech, H. L. (1983) Biochemical and immunologic analysis of hereditary myeloperoxidse deficiency. J. Clin. Invest. 71, 1297-1307.
271. Nauseef, W. M., Metcalf, J. A., Root, R. K. (1983) Role of myeloperoxidase in the respiratory burst of human neutrophils. Blood 61, 483-492.
272. Stendahl, O., Coble, B-I., Dahlgren, C., Hed, J., Molin, L. (1984) Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient. J. Clin. Invest. 73, 366-373.
273. Dri, P., Soranzo, M. R., Cramer, R., Menegazzi, R., Miotti, V., Patriarca, P. (1985) Role of myeloperoxidase in respiratory burst of human polymorphonuclear leukocytes. Studies with myeloperoxidase-deficient subjects. Inflammation 9, 21-31.
274. Dri, P., Cramer, R., Soranzo, M. R., Miotti, R., Menegazzi, R., Patriarca, P. (1984) Influence of myeloperoxidase on neutrophil functions: studies with MPO-deficient neutrophils. Agents Actions 15, 43-44.
275. Jandl, R. C., Andre-Schwartz, J., Borges-Dubois, L., Kipnes, R. S., McMurrich, B. J., Babior, B. M. (1978) Termination of the respiratory burst in human neutrophils. J. Clin. Invest. 61, 1176-1185.
276. Lynch, R. E., Fridovich, I. (1978) Permeation of the erythrocyte stroma by superoxide radical. J. Biol. Chem. 253, 4697-4699.
277. MacMicking, J. D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q. W., Sokol, K., Hutchinson, N. (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641-650.
278. Vazquez-Torres, A., Jones-Carson, J., Mastroeni, P., Ischiropoulos, H., Fang, F. C. (2000) Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 192, 227-236.
279. Murray, H. W., Teitelbaum, R. F. (1992) L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165, 513-517.
280. Schneemann, M., Schoedon, G., Hofer, S., Blau, N., Guerrero, L., Schaffner, A. (1993) Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167, 1358-1363.
281. Denis, M. (1994) Human monocytes/macrophages: NO or no NO? J. Leukoc. Biol. 55, 682-684.
282. Carreras, M. C., Pargament, G. A., Catz, S. D., Poderoso, J. J., Boveris, A. (1994) Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett. 341, 65-68.
283. Carreras, M. C., Catz, S. D., Pargament, G. A., Del Bosco, C. G., Poderoso, J. J. (1994) Decreased production of nitric oxide by human neutrophils during septic multiple organ dysfunction syndrome. Comparison with endotoxin and cytokine effects on normal cells. Inflammation 18, 151-161.
284. Evans, T. J., Buttery, L. D., Carpenter, A., Springall, D. R., Polak, J. M., Cohen, J. (1996) Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc. Natl. Acad. Sci. USA 93, 9553-9558.
285. Nathan, C., Shiloh, M. U. (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97, 8841-8848.
286. Weinberg, J. B. (1998) Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol. Med. 4, 557-591.
287. Kroncke, K. D., Fehsel, K., Kolb-Bachofen, V. (1998) Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113, 147-156.
288. Bogdan, C. (2001) Nitric oxide and the immune response. Nat. Immunol. 2, 907-916.
289. Weinberg, J. B., Misukonis, M. A., Shami, P. J., Mason, S. N., Sauls, D. L., Dittman, W. A., Wood, E. R., Smith, G. K., McDonald, B., Bachus, K. E. (1995) Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric, oxide production by blood monocytes and peritoneal macrophages. Blood 86, 1184-1195.
290. Albina, J. E. (1995) On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukoc. Biol. 58, 643-649.
291. Saran, M., Michel, C., Bors, W. (1990) Reaction of NO with O2-. Implications for the action of endothelium-derived relaxing factor (EDRF). Free Radic. Res. Commun. 10, 221-226.
292. Koppenol, W. H., Moreno, J. J., Pryor, W. A., Ischiropoulos, H., Beckman, J. S. (1992) Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 5, 834-842.
293. Huie, R. E., Padmaja, S. (1993) The reaction of NO with superoxide. Free Radic. Res. Commun. 18, 195-199.
294. Radi, R., Beckman, J. S., Bush, K. M., Freeman, B. A. (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266, 4244-4250.
295. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., Freeman, B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-1624.
296. Lymar, S. V., Khairutdinov, R. F., Hurst, J. K. (2003) Hydroxyl radical formation by O-O bond homolysis in peroxynitrous acid. Inorg. Chem. 42, 5259-5266.
297. Zhu, L., Gunn, C., Beckman, J. S. (1992) Bactericidal activity of peroxynitrite. Arch. Biochem. Biophys. 298, 452-457.
298. Brunelli, L., Crow, J. P., Beckman, J. S. (1995) The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch. Biochem. Biophys. 316, 327-334.
299. Hurst, J. K., Lymar, S. V. (1997) Toxicity of peroxynitrite and related reactive nitrogen species toward Escherichia coli. Chem. Res. Toxicol. 10, 802-810.
300. Lymar, S. V., Hurst, J. K. (1996) Carbon dioxide: physiological catalyst for peroxynitrite-mediated cellular damage or cellular protectant? Chem. Res. Toxicol. 9, 845-850.
301. Pfeiffer, S., Lass, A., Schmidt, K., Mayer, B. (2001) Protein tyrosine nitration in mouse peritoneal macrophages activated in vitro and in vivo: evidence against an essential role of peroxynitrite. FASEB J. 15, 2355-2364.
302. Pfeiffer, S., Lass, A., Schmidt, K., Mayer, B. (2001) Protein tyrosine nitration in cytokine-activated murine macrophages. Involvement of a peroxidase/nitrite pathway rather than peroxynitrite. J. Biol. Chem. 276, 34051-34058.
303. Brennan, M. L., Wu, W., Fu, X., Shen, Z., Song, W., Frost, H., Vadseth, C., Narine, L., Lenkiewicz, E., Borchers, M. T., Lusis, A. J., Lee, J. J., Lee, N. A., Abu-Soud, H. M., Ischiropoulos, H., Hazen, S. L. (2002) A tale of two controversies: defining bodi the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice and the nature of peroxidase-generated reactive nitrogen species. J. Biol. Chem. 277, 17415-17427.
304. Hurst, J. K. (2002) Whence nitrotyrosine? J. Clin. Invest. 109, 1287-1289.
305. van der Vliet, A., Eiserich, J. P., Halliwell, B., Cross, C. E. (1997) Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. J. Biol. Chem. 272, 7617-7625.
306. Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., van der Vliet, A. (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391, 393-397.
307. van Dalen, C. J., Winterbourn, C. C., Senthilmohan, R., Kettle, A. J. (2000) Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation. J. Biol. Chem. 275, 11638-11644.
308. Hazen, S. L., Zhang, R., Shen, Z., Wu, W., Podrez, E. A., MacPherson, J. C., Schmitt, D., Mitra, S. N., Mukhopadhyay, C., Chen, Y., Cohen, P. A., Hoff, H. F., Abu-Soud, H. M. (1999) Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ. Res. 85, 950-958.
309. Ischiropoulos, H. (1998) Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356, 1-11.
310. Jiang, Q., Hurst, J. K. (1997) Relative chlorinating, nitrating, and oxidizing capabilities of neutrophils determined with phagocytosable probes. J. Biol. Chem. 272, 32767-32772.
311. Baldus, S., Eiserich, J. P., Mani, A., Castro, L., Figueroa, M., Chumley, P., Ma, W., Tousson, A., White, C. R., Bullard, D. C., Brennan, M. L., Lusis, A. J., Moore, K. P., Freeman, B. A. (2001) Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J. Clin. Invest. 108, 1759-1770.
312. Eiserich, J. P., Cross, C. E., Jones, A. D., Halliwell, B., van der Vliet, A. (1996) Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J. Biol. Chem. 271, 19199-19208.
313. Kono, Y. (1995) The production of nitrating species by the reaction between nitrite and hypochlorous acid. Biochem. Mol. Biol. Int. 36, 275-283.
314. Marcinkiewicz, J., Chain, B., Nowak, B., Grabowska, A., Bryniarski, K., Baran, J. (2000) Antimicrobial and cytotoxic activity of hypochlorous acid: interactions with taurine and nitrite. Inflamm. Res. 49, 280-289.
315. Whiteman, M., Hooper, D. C., Scott, G. S., Koprowski, H., Halliwell, B. (2002) Inhibition of hypochlorous acid-induced cellular toxicity by nitrite. Proc. Natl. Acad. Sci. USA 99, 12061-12066.
316. Whiteman, M., Rose, P., Halliwell, B. (2003) Inhibition of hypochlorous acid-induced oxidative reactions by nitrite: is nitrite an antioxidant? Biochem. Biophys. Res. Commun. 303, 1217-1224.
317. 2/Cl-mediated modification of low density lipoprotein. J. Biol. Chem. 276, 1822-1828.
318. Abu-Soud, H. M., Hazen, S. L. (2000) Nitric oxide modulates the catalytic activity of myeloperoxidase. J. Biol. Chem. 275, 5425-5430.
319. Abu-Soud, H. M., Hazen, S. L. (2000) Nitric oxide is a physiological substrate for mammalian peroxidases. J. Biol. Chem. 275, 37524-37532.
320. Metchnikoff, E. (1905) Immunity in Infective Diseases. Cambridge, Cambridge University Press, 182.
321. Rous, P. (1925) The relative reaction within living mammalian tissues. I. General features of vital staining with litmus. J. Exp. Med. 41, 379-397.
322. Rous, P. (1925) The relative reaction within living mammalian tissues. II. On the mobilization of acid material within cells, and the reaction as influenced by the cell state. J. Exp. Med. 41, 399-411.
323. Sprick, M. G. (1956) Phagocytosis of M. tuberculosis and M. smegmatis stained with indicator dyes. Am. Rev. Tuberc. 74, 552-565.
324. Pavlov, E. P., Solov'ev, V. N. (1967) pH changes of cytoplasm in phagocytosis of microbes stained with indicator dyes. Biull. Eksp. Biol. Med. 63, 78-81.
325. Jensen, M. S., Bainton, D. F. (1973) Temporal changes in pH within the phagocytic vacuole of the polymorphonuclear neutrophilic leukocyte. J. Cell Biol. 56, 379-388.
326. Mandell, G. L. (1970) Intraphagosomal pH of human polymorphonuclear neutrophils. Proc. Soc. Exp. Biol. Med. 134, 447-449.
327. Kakimima, K. (1970) Metabolic control and intracellular pH during phagocytosis by polymorphonuclear leucocytes. J. Biochem. (Tokyo) 68, 177-185.
328. Segal, A. W., Geisow, M., Garcia, R., Harper, A., Miller, R. (1981) The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature 290, 406-409.
329. Geisow, M. J., D'Arcy, H. P., Young, M. R. (1981) Temporal changes of lysosome and phagosome pH during phagolysosome formation in macrophages: studies by fluorescence spectroscopy. J. Cell Biol. 89, 645-652.
330. Cech, P., Lehrer, R. I. (1984) Phagolysosomal pH of human neutrophils. Blood 63, 88-95.
331. Hurst, J. K., Albrich, J. M., Green, T. R., Rosen, H., Klebanoff, S. J. (1984) Myeloperoxidase-dependent fluorescein chlorination by stimulated neutrophils. J. Biol. Chem. 259, 4812-4821.
332. Jankowski, A., Scott, C. C., Crinstein, S. (2002) Determinants of the phagosomal pH in neutrophils. J. Biol. Chem. 277, 6059-6066.
333. Henderson, L. M. (2001) NADPH oxidase subnnit gp91phox: a proton pathway. Protoplasma 217, 37-42.
334. Henderson, L. M., Meech, R. W. (1999) Evidence that the product of the human X-linked CGD gene, gp91-phox, is a voltage-gated H(+) pathway. J. Gen. Physiol. 114, 771-786.
335. DeCoursey, T. E., Cherny, V. V., Morgan, D., Katz, B. Z., Dinauer, M. C. (2001) The gp91phox component of NADPH oxidase is not the voltage-gated proton channel in phagocytes, but it helps. J. Biol. Chem. 276, 36063-36066.
336. DeCoursey, T. E., Morgan, D., Cherny, V. V. (2002) The gp91phox component of NADPH oxidase is not a voltage-gated proton channel. J. Gen. Physiol. 120, 773-779.
337. DeCoursey, T. E. (2003) Voltage-gated proton channels and other proton transfer pathways. Physiol. Rev. 83, 475-579.
338. van Zwieten, R., Wever, R., Hamers, M. N., Weening, R. S., Roos, D. (1981) Extracellular proton release by stimulated neutrophils. J. Clin. Invest. 68, 310-313.
339. Elsbach, P., Weiss, J., Levy, O. (1999) Oxygen-independent antimicrobial systems of phagocytes. In Inflammation: Basic Principles and Clinical Correlates (J. I. Gallin, R. Snyderman, eds.), Philadelphia, PA, Lippincoll Williams & Wilkins, 801-817.
340. Ganz, T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720.
341. Ganz, T. (2004) Antimicrobial polypeptides. J. Leukoc. Biol. 75, 34-38.
342. Levy, O. (2004) Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes. J. Leukoc. Biol. 76, 909-925.
343. Olsson, I., Venge, P. (1972) Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells. Scand. J. Haematol. 9, 204-214.
344. Reeves, E. P., Lu, H., Jacobs, H. L., Messina, C. G., Bolsover, S., Gabella, G., Potma, E. O., Warley, A., Roes, J., Segal, A. W. (2002) Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416, 291-297.
345. Gratzer, W. (2002) Immunology: the Wright stuff. Nature 416, 275-277.
346. Roos, D., Winterboum, C. C. (2002) Immunology. Lethal weapons. Science 296, 669-671.
347. Fang, F. C. (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2, 820-832.
348. Tkalcevic, J., Novelli, M., Phylactides, M., Iredale, J. P., Segal, A. W., Roes, J. (2000) Impaired immunity and enhanced resistance to endotoxin in the absence of nentrophil elastase and cathepsin G. Immunity 12, 201-210.
349. Belaaouaj, A., McCarthy, R., Baumann, M., Gao, Z., Ley, T. J., Abraham, S. N., Shapiro, S. D. (1998) Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4, 615-618.
350. Belaaonaj, A. (2002) Neutrophil elastase-mediated killing of bacteria: lessons from targeted mutagenesis. Microbes Infect. 4, 1259-1264.
351. MacIvor, D. M., Shapiro, S. D., Pham, C. T., Belaaonaj, A., Abraham, S. N., Ley, T. J. (1999) Normal neutrophil function in cathepsin G-deficient mice. Blood 94, 4282-4293.
352. Belaaouaj, A., Kim, K. S., Shapiro, S. D. (2000) Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science
353. Lopez-Boado, Y. S., Espinola, M., Bahr, S., Belaaouaj, A. (2004) Neutrophil serine proteinases cleave bacterial flagellin, abrogating its host response-inducing activity. J. Immunol. 172, 509-515.
354. Ahluwalia, J., Tinker, A., Clapp, L. H., Duchen, M. R., Abramov, A. Y., Pope, S., Nobles, M., Segal, A. W. (2004) The large-conductance Ca2+-activated K+ channel is essential for innate immunity. Nature 427, 853-858.
355. Harrison, R. E., Touret, N., Grinstein, S. (2002) Microbial killing: oxidants, proteases and ions. Curr. Biol. 12, R357-R359.
356. DeCoursey, T. E. (2004) During the respiratory burst, do phagocytes need proton channels or potassium channels, or both? Sci. STKE May 11, pe21.
357. Rada, B. K., Geiszt, M., Kaldi, K., Timar, C., Ligeti, E. (2004) Dual role of phagocytic NADPH oxidase in bacterial killing. Blood 104, 2947-2953.
358. Clark, R. A. (1983) Extracellular effects of the myeloperoxidase-hydrogen peroxide-halide system. In Advances in Inflammation Research, vol. 5 (G. Weissmann, ed.), New York, NY, Raven, 107-146.
359. Fu, X., Kassim, S. Y., Parks, W. C., Heinecke, J. W. (2003) Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J. Biol. Chem. 278, 28403-28409.
360. Klebanoff, S. J., Coombs, R. W. (1996) Virucidal effect of stimulated eosinophils on human immunodeficiency virus type I. AIDS Res. Hum. Retroviruses 12, 25-29.
361. Klebanoff, S. J., Kazazi, F. (1995) Inactivation of human immunodeficiency virus type 1 by the amine oxidase-peroxidase system. J. Clin. Microbiol. 33, 2054-2057.
362. Klebanoff, S. J., Coombs, R. W. (1992) Viricidal effect of polymorphonuclear leukocytes on HIV-1: role of the myeloperoxidase system. J. Clin. Invest. 89, 2014-2017.
363. Chase, M. J., Klebanoff, S. J. (1992) Viricidal effect of stimulated human mononuclear phagocytes on human immunodeficiency virus type I. Proc. Natl. Acad. Sci. USA 89, 5582-5585.
364. Nathan, C. F., Murray, H. W., Wiebe, M. E., Rubin, B. Y. (1983) Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158, 670-689.
365. Legrand-Poels, S., Varia, D., Pincemail, J., Van de Vorst, A., Pielle, J. (1990) Activation of human immunodeficiency virus type I by oxidative stress. AIDS Res. Hum. Retroviruses 6, 1389-1397.
366. Schreck, K., Rieber, P., Bacuerle, P. A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor mid HIV-1. EMBO J. 10, 2247-2258.
367. 2- vanadate. Free Radic. Biol. Med. 20, 813-820.
368. Klebanoff, S. J., Mehlin, C., Headley, C. M. (1997) Activation of the HIV-1 long terminal repeat and viral replication by dimethylsulfoxide and related solvents. AIDS Res. Hum. Retroviruses 13, 1221-1227.
369. Klebanoff, S. J., Watts, D. H., Mehlin, C., Headley, C. M. (1999) Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type I long terminal repeat, cytokine production, and NF-κB. J. Infect. Dis. 179, 653-660.
370. Klebannoff, S. J., Headley, C. M. (1999) Activation of the human immunodeficiency virus-1 long terminal repeat by respiratory burst oxidants of neutrophils. Blood 93, 350-356.
371. Aguer, K. (1947) Detoxicating effect of verdoperoxidase on toxins. Nature 159, 271-272.
372. Agner, K. (1950) Studies on peroxidative detoxification of purified diphtheria toxin. J. Exp. Med. 92, 337-347.
373. Clark, R. A., Klebanoff, S. J. (1979) Myeloperoxidase-mediated platelet release reaction. J. Clin. Invest. 63, 177-183.
374. Clark, R. A., Klebanoff, S. J. (1980) Neutrophil-platelet interaction mediated by myeloperoxidase and hydrogen peroxide. J. Immunol. 124, 399-405.
375. Henderson, W. R., Chi, K. Y., Klebanoff, S. J. (1980) Eosinophil peroxidase-induced mast cell secretion. J. Exp. Med. 152, 265-279.
376. Chi, K. Y., Henderson, W. R. (1984) Ultrastructure of mast cell degranulation induced by eosinophil peroxidase: use of diaminobenzidine cytochemistry by scanning electron microscopy. J. Histochem. Cytochem. 32, 337-341.
377. Stendahl, O., Molin, L., Lindroth, M. (1983) Granulocyte-mediated release of histamine from mast cells. Effect of myeloperoxidase and its inhibition by antiinflammatory sulfone compounds. Int. Arch. Allergy Recenti Prog. Med. 76, 277-284.
378. Lanza, K., Musto, P., Franze, D. (1985) Hereditary myeloperoxidase deficiency syndrome: clinical and haematological data of 10 cases. Recenti Prog Med. 76, 71-78.
379. Lanza, K., Fietta, A., Spisani, S., Castoldi, C. L., Traniello, S. (1987) Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasms? J. Clin. Lab. Immunol. 22, 175-180.
380. Lanza, F. (1998) Clinical manifestation of myeloperoxidase deficiency. J. Mol. Med. 76, 676-681.
381. Lanza, K., Giuliani, A. L., Amelotti, F., Spisani, S., Traniello, S., Castoldi, G. (1988) Depressed neutrophil-mediated tumor cell cytotoxicity in subjects affected by hereditary myeloperoxidase deficiency and secondary neoplasia. Haematologica 73, 355-358.
382. London, S. J., Lehman, T. A., Taylor, J. A. (1997) Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res. 57, 5001-5003.
383. van Zyl, J. M., Basson, K., van der Walt, B. J. (1989) Stimulation of the chlorinating activity of human myeloperoxidase by thyroid hormones and analogues. Horm. Metab. Res. 21, 441-444.
384. van Zyl, J. M., van der Walt, B. J., Kriegler, A. (1993) Thyroxine-supported oxidation in the myeloperoxidase system. Horm. Metab. Res. 25, 569-572.
385. Yip, C., Klebanoff, S. J. (1963) Synthesis in vitro of thyroxine from diiodotyrosine by myeloperoxidase and by a cell-free preparation of beef thyroid glands. I. Glucose-glucose oxidase system. Biochim. Biophys. Acta 74, 747-755.
386. Taurog, A., Dorris, M. L. (1992) Myeloperoxidase-catalyzed iodination and coupling. Arch. Biochem. Biophys. 296, 239-246.
387. Klebanoff, S. J., Segal, S. J. (1960) The inactivation of estradiol by peroxidase. J. Biol. Chem. 235, 52-55.
388. Klebanoff, S. J. (1977) Estrogen binding by leukocytes during phagocytosis. J. Exp. Med. 145, 983-998.
389. Tiruppathi, C., Naqvi, T., Wu, Y., Vogel, S. M., Minshall, R. D., Malik, A. B. (2004) Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells. Proc. Natl. Acad. Sci. USA 101, 7699-7704.
390. Piedrafita, K. J., Molander, R. B., Vansant, G., Orlova, E. A., Pfahl, M., Reynolds, W. F. (1996) An Alu element in the myeloperoxidase promoter contains a composite SPI-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271, 14412-14420.
391. Reynolds, W. F., Chang, E., Douer, D. Ball, E. D., Kanda, V. (1997) An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood 90, 2730-2787.
392. Cascorbi, I., Henning, S., Brockmoller, J., Cephart, J., Meisel, C., Muller, J. M., Loddenkemper, H., Roots, I. (2000) Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463A of the myeloperoxidase gene. Cancer Res. 60, 644-649.
393. Le Marchand, L., Seifried, A., Lum, A., Wilkens, I. H. (2000) Association of the myeloperoxidase-468G → a polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 9, 181-184.
394. Schabath, M. B., Spitz, M. K., Zhang, X., Delclos, G. L., Wu, X. (2000) Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis 21, 1168-1166.
395. Kantarci, O. H., Lesnick, T. G., Yang, P., Meyer, R. L., Hebriuk, D. D., McMurray, C. T., Weinsheuker, B. G. (2002) Myeloperoxidase -463 (G→A) polymorphism associated with lower risk of lung cancer. Mayo Clin. Proc. 77, 17-22.
396. Feyler, A., Voho, A., Bouchardy, C., Kuokkanen, K., Dayer, P., Hirvonen, A., Beuhamou, S. (2002) Point: myeloperoxidase -463G → a polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 11, 1550-1554.
397. Schabath, M. B., Spitz, M. R., Delclos, G. L., Gunn, G. B., Whitehead, L. W., Wu, X. (2002) Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am. J. Ind. Med. 42, 29-37.
398. Schabath, M. B., Spitz, M. R., Hong, W. K., Delclos, G. L., Reynolds, W. F., Gunn, G. B., Whitehead, L. W., Wu, X. (2002) A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer 37, 35-40.
399. Wu, X., Schabath, M. B., Spitz, M. K. (2003) Myeloperoxidase promoter region polymorphism and lung cancer risk. Methods Mol. Med. 75, 121-133.
400. Dally, H., Gassner, K., Jager, B., Sehmezer, P., Spiegelhalder, B., Edler, L., Drings, P., Dienemann, H., Schulz, V., Kayser, K., Bartsch, H., Risch, A. (2002) Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO-463 A allele is associated with reduced risk for small cell lung cancer in smokers. Int. J. Cancer 102, 530-535.
401. Dally, H., Bartsch, H., Risch, A. (2003) Correspondence re: Feyler et al., point: myeloperoxidase (-463)G → a polymorphism and lung cancer risk. Cancer Epidemiol. Biomark. Prev., 11: 1550-1554. 2002, and Xu et al., counterpoint: the myeloperoxidase (-463)G → a polymorphism does not decrease lung cancer susceptibility in caucasians. 11: 1555-1559. 2002. Cancer Epidemiol. Biomarkers Prev. 12, 683.
402. Caporaso, N. E. (2002) Why have we failed to find the low penetrance genetic constituents of common cancers? Cancer Epidemiol. Biomarkers Prev. 11, 1544-1549.
403. Chevrier, I., Stucker, I., Houllier, A. M., Cenee, S., Beaune, P., Laurent-Puig, P., Loriot, M. A. (2003) Myeloperoxidase: new polymorphisms and relation with lung cancer risk. Pharmacogenetics 13, 729-739.
404. Xu, L. L., Liu, C., Miller, D. P., Zhou, W., Lynch, T. J., Wain, J. C., Su, L. Christiani, D. C. (2002) Counterpoint: the myeloperoxidase-463G → a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol. Biomarkers Prev. 11, 1555-1559.
405. Misra, R. R., Tangrea, J. A., Virtamo, J., Ratnasinghe, D., Andersen, M. R., Barrett, M., Taylor, P. H., Albanes, D. (2001) Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Lett. 164, 161-167.
406. Hung, R. J., Boffetta, P., Brennan, P., Malaveille, C., Gelatti, U., Placidi, D., Carta, A., Hantefeville, A., Porru, S. (2004) Genetic polymorphisms of MPO, COMT, MnSOD, NQOI, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 25, 973-978.
407. Pakakasama, S., Chen, T. T., Frawley, W., Muller, C., Douglass, E. C., Tomlinson, G. E. (2003) Myeloperoxidase promoter polymorphism and risk of hepatoblastoma. Int. J. Cancer 106, 205-207.
408. Tsuruta, Y., Subrahmanyam, V. V., Marshall, W., O'Brien, P. J. (1985) Peroxidase-mediated irreversible binding of arylamine carcinogens to DNA in intact polymorphonuclear leukocytes activated by a tumor promoter. Chem. Biol. Interact. 53, 25-35.
409. Mallet, W. C., Mosebrook, D. H., Trush, M. A. (1991) Activation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to diolepoxidex by human polymorphonuelear leukocytes or myeloperoxidase. Carcinogenenesis 12, 521-524.
410. Petruska, J. M., Mosebrook, D. R., Jakab, G. J., Trush, M. A. (1992) Mycloperoxidase-enhaneed formation of (+-)-trans-7,8-dihydroxy-7,8- dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis 13, 1075-1081.
411. Josephy, P. D (1996) The role of peroxidase-catalyzed activation of aromatic amines in breast cancer. Mutagenesis 11, 3-7.
412. Henderson, J. P., Byun, J., Takeshita, J., Heinecke, J. W. (2003) Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. J. Biol. Chem. 278, 23522-23528.
413. Jiang, Q., Blount, B. C., Ames, B. N. (2003) 5-Chlorouracil, a marker of DNA damage from hypochlorous acid during inflammation. A gas chromatography-mass spectrometry assay. J. Biol. Chem. 278, 32834-32840.
414. Rojas, M., Godschalk, R., Alexandrov, K., Cascorbi, I., Kriek, E., Ostertag, J., Van Schooten, F. J., Bartsch, H. (2001) Myeloperoxidase -463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar-treated patients. Cnrcinoganesis 22, 1015-1018.
415. Malle, E., Buch, T., Crone, H. J. (2003) Myeloperoxidase in kidney disease. Kidney Int. 64, 1956-1967.
416. Johnson, R. J., Lovett, D., Lehrer, R. I., Couser, W. G., Klebanoff, S. J. (1994) Role of oxidants and proteases in glomerular injury. Kidney Int. 45, 352-359.
417. Johnson, R. J., Couser, W. C., Chi, E. Y., Adler, S., Klebanoff, S. J. (1987) New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J. Clin. Invest. 79, 1379-1387.
418. Johnson, R. J., Cuggenheim, S. J., Klebanoff, S. J., Ochi, R. F., Wass, A., Baker, P., Schulze, M., Couser, W. C. (1988) Morphologic correlates of glomerular oxidant injury induced by the myeloperoxidase-hydrogen peroxide-halide system of the neutrophil. Lab. Invest. 58, 294-301.
419. 2-halide system in immune complex nephritis. Kidney Int. 32, 342-349.
420. Saeki, T., Kuroda, T., Monta, T., Suzuki, K., Arakawa, M., Kawasaki, K. (1995) Significance of myeloperoxidase in rapidly progressive glomerulonephritis. Am. J. Kidney Dis. 26, 13-21.
421. Xiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., Maeda, N., Falk, R. J., Jennette, J. C. (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 110, 955-963.
422. D'Agati, V. (2002) Antineutrophil cytoplasmic antibody and vasculitis: much more than a disease marker. J. Clin. Invest. 110, 919-921.
423. Reumaux, D., de Boer, M., Meijer, A. B., Duthilleul, P., Roos, D. (2003) Expression of myeloperoxidase (MPO) by neutrophils is necessary for their activation by anti-neutrophil cytoplasm autoantibodies (ANCA) against MPO. J. Leukoc. Biol. 73, 841-849.
424. Reynolds, W. E., Stegeman, C. A., Tervaert, J. W. (2002) -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis. Clin. Immunol. 103, 154-160.
425. Pecoits-Filho, R., Stenvinkel, P., Marehlewska, A., Heimburger, O., Barany, P., Hoff, C. M., Holmes, C. J., Suliman, M., Lindholm, B., Schalling, M., Nordfors, L. (2003) A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int. Suppl. May, S172-S176.
426. Ishida-Okawara, A., Oharaseki, T., Tukahashi, K., Hashimoto, Y., Aratani, Y., Koyama, H., Maeda, N., Naoe, S., Suzuki, K. (2001) Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production. Inflammation 25, 381-387.
427. Suzuki, K. (2001) Neutrophil functions of patients with vasculitis related to myeloperoxidase-specific anti-neutrophil antibody. Int. J. Hematol. 74, 134-143.
428. Malle, E., Woenckhaus, C., Waeg, C., Esterbauer, H., Grone, E. F., Grone, H. J. (1997) Immnunological evidence for hypochlorite-modified proteins in human kidney. Am. J. Pathol. 150, 603-615.
429. Himmelfarb, J., McMenamin, M. E., Loseto, C., Heinecke, J. W. (2001) Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic. Biol. Med. 31, 1163-1169.
430. Johnson, K. J., Fantone, J. C. I., Kaplan, J., Ward, P. A. (1981) In vivo damage of rat lungs by oxygen metabolites. J. Clin. Invest. 67, 983-993.
431. Cantin, A. M., North, S. L., Fells, G. A., Hubbard, R. C., Crystal, R. G. (1987) Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79, 1665-1673.
432. Buss, I. H., Darlow, B. A., Winterbourn, C. C. (2000) Elevated protein carbonyls ami lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants. Pediatr. Res. 47, 640-645.
433. Hazen, S. L., Hsu, E. E., Gaut, J. P., Crowley, J. R., Heinecke, J. W. (1999) Modification of proteins and lipids by myeloperoxidase. Methods Enzymol. 300, 88-105.
434. Heinecke, J. W. (1999) Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J. Lab. Clin. Med. 133, 321-325.
435. Chisolm III, C. M., Hazen, S. L., Fox, P. L., Catheart, M. K. (1999) The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J. Biol. Chem. 274, 25959-25962.
436. Heinecke, J. W. (1997) Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr. Opin. Lipidol. 8, 268-274.
437. Heinecke, J. W. (1998) Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141, 1-15.
438. Podrez, E. A., Abu-Soud, H. M., Hazen, S. L. (2000) Myeloperoxidase- generated oxidants and atherosclerosis. Free Radic. Biol. Med. 28, 1717-1725.
439. Heinecke, J. W. (1999) Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall. FASEB J. 13, 1113-1120.
440. Chisolm, G. M., Steinberg, D. (2000) The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28, 1815-1826.
441. Gaut, J. P., Heinecke, J. W. (2001) Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis. Trends Cardiovasc. Med. 11, 103-112.
442. Heinecke, J. W. (2003) Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am. J. Cardiol. 91, 12A-16A.
443. Carr, A. C., Myzak, M. C., Stocker, R., McCall, M. R., Frei, B. (2000) Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis. FEBS Lett. 487, 176-180.
444. Heinecke, J. W., Li, W., Mueller, D. M., Bohrer, A., Turk, J. (1994) Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry 33, 10127-10136.
445. -". Free Radic. Biol. Med. 16, 143-148.
446. Jerlich, A., Hammel, M., Horakova, L., Schaur, R. J. (2001) An improved method for the sensitive monitoring of low density lipoprotein modification by myeloperoxidase. Redox Rep. 6, 257-264.
447. Yang, C. Y., Gu, Z. W., Yang, M., Lin, S. N., Garcia-Prats, A. J., Rogers, L. K., Welty, S. E., Smith, C. V. (1999) Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro. J. Lipid Res. 40, 686-698.
448. Yang, C-Y., Wang, J., Krutchinsky, A. N., Chait, B. T., Morrisett, J. D., Smith, C. V. (2001) Selective oxidation in vitro by myeloperoxidase of the N-terminal amine in apolipoprotein 15-100. J. Lipid Res. 42, 1891-1896.
449. Carr, A. C., Decker, E. A., Park, Y., Frei, B. (2001) Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids. Free Radic. Biol. Med. 31, 62-72.
450. Exner, M., Hermann, M., Hofbauer, R.. Hartmann, B., Kapiotis, S., Gmeiner, B. (2004) Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL. Free Radic. Biol. Med. 37, 146-155.
451. Podrez, E. A., Schmitt, D., Hoff, H. F., Hazen, S. L. (1999) Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103, 1547-1560.
452. Byun, J., Mueller, D. M., Fabjan, J. S., Heinecke, J. W. (1999) Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein. FEBS Lett. 455, 243-246.
453. Heller, J. L. Crowley, J. R., Hazen, S. L., Salvay, D. M., Wagner, P., Pennathur, S., Heinecke, J. W. (2000) p-Hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima. J. Biol. Chem. 275, 9957-9962.
454. Bergt, C., Marsche, G., Panzenboeck, U., Heinecke, J. W., Malle, E., Sattler, W. (2001) Human neutrophils employ the myeloperoxidase/hydrogen peroxide/chloride system to oxidatively damage apolipoprotein A-I. Eur. J. Biochem. 268, 3523-3531.
455. Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., Geary, R. L., Oram, J. F., Heinccke, J. W. (2004) The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc. Natl. Acad. Sci. USA 101, 13032-13037.
456. McCormick, M. L., Gaut, J. P., Lin, T. S., Britigan, B. E., Buettner, G. R., Heinecke, J. W. (1998) Electron paramagnetic resonance detection of free tyrosyl radical generated by myeloperoxidase, lacloperoxidase, and horseradish peroxidase. J. Biol. Chem. 273, 32030-32037.
457. Leeuwenburgh, C., Rasmussen, J. E., Hsu, F. F., Mueller, D. M., Pennathur, S., Heinecke, J. W. (1997) Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272, 3520-3526.
458. Whitman, S. C., Hazen, S. L., Miller, D. B., Hegele, R. A., Heinecke, J. W., Huff, M. W. (1999) Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages. Arterioscler. Thromb. Vasc. Biol. 19, 1238-1249.
459. Daugherty, A., Dunn, J. L., Rateri, D. L., Heinecke, J. W. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444.
460. 2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur. J. Biochem. 267, 4495-4503.
461. Sugiyama, S., Okada, Y., Sukhova, G. K., Virmani, R., Heinecke, J. W., Libby, P. (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am. J. Pathol. 158, 879-891.
462. Malle, E., Hazell, L., Stocker, R., Sattler, W., Esterbauer, H., Waeg, G. (1995) Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler. Thromb. Vasc. Biol. 15, 982-989.
463. Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E., Stocker, R. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97, 1535-1544.
464. Hazell, L. J., Baernthaler, C., Stocker, R. (2001) Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis. Free Radic. Biol. Med. 31, 1254-1262.
465. Woods, A. A., Linton, S. M., Davies, M. J. (2003) Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem. J. 370, 729-735.
466. Woods, A. A., Davies, M. J. (2003) Fragmentation of extracellular matrix by hypochlorous acid. Biochem. J. 376, 219-227.
467. Leeuwenburgh, C., Hardy, M. M., Hazen, S. L., Wagner, P., Oh-ishi, S., Steinbrecher, U. P., Heinecke, J. W. (1997) Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272, 1433-1436.
468. Beckman, J. S., Ye, Y. Z., Anderson, P. C., Chen, J., Accavitti, M. A., Tarpey, M. M., White, C. R. (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe Seyler 375, 81-88.
469. Byun, J., Henderson, J. P., Mueller, D. M., Heinecke, J. W. (1999) 8-Nitro-2′-deoxyguanosine, a specific marker of oxidation by reactive nitrogen species, is generated by the myeloperoxidase-hydrogen peroxide-nitrite system of activated human phagocytes. Biochemistry 38, 2590-2600.
470. Shishehbor, M. H., Aviles, R. J., Brennan, M. L., Fu, X., Goormastic, M., Pearce, C. L., Gokce, N., Keaney Jr., J. F., Penn, M. S., Sprecher, D. L., Vita, J. A., Hazen, S. L. (2003) Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289, 1675-1680.
471. Kirk, E. A., Dinauer, M. C., Rosen, H., Chait, A., Heinecke, J. W., LeBoeuf, R. C. (2000) Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 20, 1529-1535.
472. Noguchi, N., Nakano, K., Aratani, Y., Koyama, H., Kodama, T., Niki, E. (2000) Role of myeloperoxidase in the neutrophil-induced oxidation of low density lipoprotein as studied by myeloperoxidase-knockout mouse. J. Biochem. (Tokyo) 127, 971-976.
473. Brennan, M. L., Anderson, M. M., Shih, D. M., Qu, X. D., Wang, X., Mehta, A. C., Lim, L. L., Shi, W., Hazen, S. L., Jacob, J. S., Crowley, J. R., Heinecke, J. W., Lusis, A. J. (2001) Increased atherosclerosis in myeloperoxidase-deficient mice. J. Clin. Invest. 107, 419-430.
474. Nauseef, W. M. (2001) The proper study of mankind. J. Clin. Invest. 107, 401-403.
475. Zhang, R., Brennan, M. L., Fu, X., Aviles, R. J., Pearce, G. L., Penn, M. S., Topol, K. J., Sprecher, D. L., Hazen, S. L. (2001) Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286, 2136-2142.
476. Brennan, M. L., Penn, M. S., Van Lente, F., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., Nissen, S. E., Hazen, S. L. (2003) Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 349, 1595-1604.
477. Baldus, S., Heeschen, C, Meinertz, T., Zeiher, A. M., Eiserich, J. P., Munzel, T., Simoons, M. L., Hamm, C. W. (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108, 1440-1445.
478. Cayley Jr., W. E. (2004) Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 350, 516-518.
479. Hiramatsu, K., Rosen, H., Heinecke, J. W., Wolfbauer, C., Chait, A. (1987) Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis 7, 55-60.
480. Llodra, J., Angeli, V., Liu, J., Trogan, E., Fisher, E. A., Randolph, C. J. (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. USA 101, 11779-11784.
481. Grayston, J. T. (2000) Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J. Infect. Dis. 181 (Suppl. 3), S402-S410.
482. Ludewig, B., Krebs, P., Scandella, E. (2004) Immunopathogenesis of atherosclerosis. J. Leukoc. Biol. 76, 300-306.
483. Nagra, R. M., Becher, R., Tourtellotte, W. W., Antel, J. P., Gold, D., Paladino, T., Smith, R. A., Nelson, J. R., Reynolds, W. F. (1997) Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J. Neuroimmunol. 78, 97-107.
484. Ramsaransing, G., Teelken, A., Prokopenko, V. M., Arutjunyan, A. V., De Keyser, J. (2003) Low leucocyte myeloperoxidase activity in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 74, 953-955.
485. Brennan, M., Gaur, A., Pahuja, A., Lusis, A. J., Reynolds, W. F. (2001) Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis. J. Neuroimmunol. 112, 97-105.
486. Reynolds, W. F., Rhees J., Maciejewski, D., Paladino, T., Sieburg, H., Maki, R. A., Masliah, E. (1999) Myeloperoxidase polymorphism is associated with gender-specific risk for Alzheimer's disease. Exp. Neurol. 155, 31-41.
487. Jolivalt, C., Leininger-Muller, B., Drozdz, R., Naskalski, J. W., Siest, G. (1996) Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain. Neurosci. Lett. 210, 61-64.
488. Jolivalt, C., Leininger-Muller, B., Bertrand, P., Herber, R., Christen, Y., Siest, G. (2000) Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic. Biol. Med. 28, 129-140.
489. Green, P. S., Mendez, A. J., Jacob, J. S., Crowley, J. R., Growdon, W., Hyman, B. T., Heinecke, J. W. (2004) Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. J. Neurochem. 90, 724-733.
490. Reynolds, W. F., Hiltunen, M., Pirskanen, M., Mannermaa, A., Helisalini, S., Lehtovirta, M., Alafuzoff, I., Soininen, H. (2000) MPO and APOEε4 polymorphisms interact to increase risk for AD in Finnish males. Neurology 55, 1284-1290.
491. Crawford, F. C., Freeman, M. J., Schinka, J. A., Morris, M. D., Abdullah, L. I., Richards, D., Sevush, S., Duara, R., Mullan, M. J. (2001) Association between Alzheimer's disease and a functional polymorphism in the myeloperoxidase gene. Exp. Neurol. 167, 456-459.
492. Leininger-Muller, B., Hoy, A., Herbeth, B., Pfister, M., Serot, J. M., Stavljenic-Rukavina, M., Massana, L., Passmore, P., Siest, G., Visvikis, S. (2003) Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study. Neurosci. Lett. 349, 95-98.
493. Combarros, O., Infante, J., Llorca, J., Pena, N., Fernandez-Viadero, C., Berciano, J. (2002) The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis. Neurosci. Lett. 326, 33-36.
494. Styezynska, M., Religa, D., Pfeffer, A., Luczywek, E., Wasiak, B., Styezynski, G., Peplonska, B., Gabryelewicz, T., Golebiowski, M., Kobrys, M., Barcikowska, M. (2003) Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci. Lett. 344, 99-102.
495. Hoy, A., Leininger-Muller, B., Poirier, O., Siest, G., Gautier, M., Elbaz, A., Amarenco, P., Visvikis, S. (2003) Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome. Atherosclerosis 167, 223-230.
496. Wu, D. C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., Przedborski, S. (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 100, 6145-6150.
497. Pennathur, S., Jackson-Lewis, V., Przedborski, S., Heinecke, J. W. (1999) Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J. Biol. Chem. 274, 34621-34628.